The Presidential Instruction (Inpres) No. 6/2016 on Acceleration of Pharmaceutical and Medical Equipment Industry Development and Domestic Content Rules (TKDN) aims to encourage the domestic health industry to aggressively produce medical equipment in the country.
Through this program, Kadin Indonesia targets global private–sector investment in the health industry.
Kadin Indonesia is committed to strengthening the health sector industry through advocacy and strategic policy recommendations.
We continue to support the national health sector by accommodating the needs and interests of the national health industry.
Kadin Indonesia in the Health Sector has compiled a White Paper containing views and recommendations on the Draft Government Regulation (RPP) of Law No. 17/2023. RPP Law No. 17/2023 on pharmaceuticals and medical devices. This White Paper was prepared and submitted to the Ministry of Health to understand better the impact and implications of RPP Health Law No. 17/2023 on Indonesia's health sector.
In addition, Kadin Indonesia also has a Health program that seeks to target global investment from the private sector in the healthcare industry. Some of its programs include the One Shot Campaign and Business Law : Healthcare Market.
The program will focus on pillars such as research and development (R&D) of vaccines, therapeutics, and diagnostics, harmonization of regional healthcare supply, partnerships in genomics, digital surveillance, and supply chain connectivity for health resilience in Indonesia.
Jl. H. R. Rasuna Said Blok X-5 No.Kav. 2-3, Kuningan, Jakarta 12950
National Economy
Regional Economy